PNO-1

N/A

Report date: 2022/01/10 18:08:24
NME

Base Information

Drug NamePNO-1
Drug Alias NamePNO-1
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionAnti-PSMA
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsContrast agentsPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsContrast agentsPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A